Skip to main content


Fig. 3 | Thrombosis Journal

Fig. 3

From: Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting

Fig. 3

Individual dabigatran plasma trough concentration measured on two separate occasions using HPLC MS-MS (n = 7). High inter- and intrapatient variability was observed. Conceptually, due to this variability, the clinical application of therapeutic drug monitoring is challenging. Shaded area represents the on-therapy range (30 ng/mL to 130 ng/mL)

Back to article page